Analysis of Percutaneous Ablations for Cancer Treatment
Completed
Conditions studied: Cancer
In brief
This is a study involving patients with cancer who are referred by their treating physician for percutaneous locoregional therapies. Patient's clinical and radiology findings, pathology findings, survival, treatment responses, and complications after their locoregional therapy will be studied.
Key facts
- Study ID
- NCT01563679
- Run by
- Emory University
- People needed
- 26
- Starts
- 2012-02-01
- Expected to finish
- 2014-01-01
- Last updated by the study team
- 2014-05-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 18yrs of age
- Cancer diagnosis
- Candidate for Locoregional therapy
- Willingness to sign informed consent
You may not qualify if…
- Unable to sign informed consent
- Patients not eligible for locoregional therapies
Where it is running
- Emory University Hospital — Altanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.